Loading data
SPRONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 12.59 m USD | 371 k USD | 933 k USD | 2.5 m USD | 3.07 m USD |
| Research and development expense | 38.47 m USD | 96.76 m USD | 51.44 m USD | 47.59 m USD | 64.53 m USD |
| Operating profit | 6.31 m USD | -73.36 m USD | 21.48 m USD | -42.2 m USD | -87.97 m USD |
| Profit before tax | 8.83 m USD | -68.57 m USD | 25.4 m USD | -46.42 m USD | -89.76 m USD |
| Income tax expense | 261 k USD | 0 USD | 2.6 m USD | 0 USD | — |
| Net income (reported basis) | 8.57 m USD | -68.57 m USD | 22.81 m USD | -46.42 m USD | -89.76 m USD |
| Net income attributable to common shareholders | — | — | — | 46.42 m USD | -89.76 m USD |
| Basic earnings per share | 0.15 USD/share | -1.27 USD/share | 0.43 USD/share | -1.23 USD/share | -2.91 USD/share |
| Diluted earnings per share | 0.15 USD/share | -1.27 USD/share | 0.43 USD/share | -1.23 USD/share | -2.91 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.